DGX · Healthcare · $25.5B
$231.09-0.85%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 39 Medical - Diagnostics & Research peers
Quarterly Revenue Growth
“매출이 전년 동기 대비 10.2% 늘었고, 이 성장의 거의 전부가 기존 사업에서 나온 유기적 성장이에요.”
In the company's words · 2026 2분기 earnings call